G. Shen, X. Lv, W. Bao
SHORT COMMUNICATION
N2, DMSO (2.0 mL) was added by syringe. Then, isothiocyanates
(0.7 mmol) were added by syringe under a counter flow of N2. The
reaction mixture was stirred for 24 h at 95(115) °C. The reaction
was monitored by TLC. After the starting material was consumed
completely, the reaction was stopped and cooled to room tempera-
ture. H2O (20 mL) was added to the solvent, and the mixture was
extracted with EtOAc (3ϫ15 mL). The extracts were combined
and washed with water (2ϫ10 mL) and brine (15 mL) and dried
(MgSO4). After evaporating the solvent under reduced pressure,
the residue was purified by column chromatography on silica gel
to give the pure product.
3-amine (Table 3, Entries 1–8). To our delight, generally the
reactions proceeded successfully in moderate to excellent
yields, although higher temperatures were required. Several
2-bromoanilines were coupled with various isothiocyanates
from moderate to excellent yields (Table 3, Entries 1–5). Fi-
nally, 2,6-dibromopyridin-3-amine was also tested. The
yield was relatively lower than that of the 2-bromoanilines,
probably because the electronic effect of 2,6-dibromopyr-
idin-3-amine (6-Br) influenced the intramolecular coupling
process (Table 3, Entries 6 and 7).
A plausible mechanism, which accounts for the forma-
tion of the N-substituted-2-aminobenzothiazoles from the
2-iodoanilines and isothiocyanates, is shown in Scheme 2.
The nucleophilic N atom of 2-iodoanilines a would attack
the carbon atom on NCS and intermediate d could be
formed in the presence of a proper base. Coordination of
copper to d gave e. Reductive elimination released product
c with concomitant regeneration of the catalyst.
Supporting Information (see footnote on the first page of this arti-
1
cle): Spectroscopic data and copies of the H and 13C NMR spec-
tra.
Acknowledgments
This work was financially supported by the Specialized Research
Fund for the Doctoral Program Foundation of Higher Education
of China (No. 2060335036).
[1] a) A. C. Gyorkos, C. P. Corrette, S. Y. Cho, T. M. Turner, S. A.
Pratt, K. Aso, M. Kori, M. Gyoten, Worldwide Patent 2005,
044, 793, 2005; [Chem. Abstr. 2005, 142, 482]; b) A. D. Jordan,
C. Luo, A. B. Reitz, J. Org. Chem. 2003, 68, 8693; c) A. R.
Katritzky, D. O. Tymoshenko, D. Monteux, V. Vvedensky, G.
Nikonov, C. B. Cooper, M. Deshpande, J. Org. Chem. 2000, 65,
8059; d) R. A. Glennon, J. J. Gaines, M. E. Rogers, J. Med.
Chem. 1981, 24, 766.
[2] J. Van Heusden, R. Van Ginckel, H. Bruwiere, P. Moelans, B.
Janssen, W. Floren, B. J. van der Leede, J. van Dun, G. Sanz,
M. Venet, L. Dillen, C. Van Hove, G. Willemsens, M. Janicot,
W. Wouters, Br. J. Cancer 2002, 86, 605.
[3] M. S. Gomaa, J. L. Armstrong, B. Bobillon, G. J. Veal, A.
Brancale, C. P. F. Redfern, C. Simons, Bioorg. Med. Chem.
2008, 16, 8301.
[4] a) C. Liu, J. Lin, S. Pitt, R. F. Zhang, J. S. Sack, S. E. Kiefer,
K. Kish, A. M. Doweyko, H. Zhang, P. H. Marathe, J.
Trzaskos, M. Mckinnon, J. H. Dodd, J. C. Barrish, G. L. Schi-
even, K. Leftheris, Bioorg. Med. Chem. Lett. 2008, 18, 1874; b)
K. Takagi, Chem. Lett. 1986, 265.
Scheme 2. Plausible mechanism.
[5] a) E. Y. Song, N. Kaur, M. Y. Park, Y. Jin, K. Lee, G. Kim,
K. Y. Lee, J. S. Yang, J. H. Shin, K. Y. Nam, K. T. No, G. Han,
Eur. J. Med. Chem. 2008, 43, 1519; b) P. L. Sangwan, J. L.
Koul, S. Koul, M. V. Reddy, N. Thota, I. A. Khan, A. Kumar,
N. P. Kallia, G. N. Qazi, Bioorg. Med. Chem. 2008, 16, 9847;
c) D. Armenise, N. de Laurentis, A. Reho, A. Rosato, F. Mor-
lacchi, J. Heterocycl. Chem. 2004, 41, 771.
[6] J. M. Sprague, A. H. Land in Heterocyclic Compounds (Ed.:
R. C. Elderfield), Wiley, New York, 1957, vol. 5, ch. 8, p. 484.
[7] a) T. Suzuki, S. Igari, A. Hirasawa, M. Hata, M. Ishiguro, H.
Fujieda, Y. Itoh, T. Hirano, H. Nakagawa, M. Ogura, M. Mak-
ishima, G. Tsujimoto, N. Miyata, J. Med. Chem. 2008, 51,
7640; b) H. F. Motiwala, R. Kumar, A. K. Chakraborti, Aust.
J. Chem. 2007, 60, 369; c) F. Delmas, A. Avellaneda, C.
Di Giorgio, M. Robin, E. De Clercq, P. Timon-David, J. P.
Galy, Eur. J. Med. Chem. 2004, 39, 685; d) J. Das, R. V. Mo-
quin, J. Lin, C. J. Liu, A. M. Doweyko, H. F. DeFex, Q. Fang,
S. Pang, S. Pitt, D. R. Shen, G. L. Schieven, J. C. Barrish, J.
Wityak, Bio. Med. Chem. Lett. 2003, 13, 2587; e) H. Tanikawa,
K. Ishii, S. Kubota, S. Yagai, A. Kitamura, T. Karatsu, Tetra-
hedron Lett. 2008, 49, 3444.
Conclusions
In summary, we have developed a novel, efficient, and
concise method to synthesize N-substituted-2-aminobenzo-
thiazoles under ligand-free copper(I)-catalyzed conditions.
A simple “one-pot” operation was conducted, readily avail-
able starting materials were employed, and relatively mild
conditions were applied. Various N-substituted-2-amino-
benzothiazoles, which might be potentially applicable in the
pharmaceutical and biochemical areas, were conveniently
synthesized in moderate to excellent yields. The reaction is
also a good example of a ligand-free copper(I)-catalyzed
one-pot cascade process.
Experimental Section
General Procedure: An oven-dried Schlenk tube equipped with a
Teflon valve was charged with a magnetic stir bar, K2CO3
(0.4 mmol, 100 mol-%), CuI (0.06 mmol, 15 mol-%), and 2-halo-
anilines (0.4 mmol). The tube was evacuated and backfilled with
N2 (this procedure was repeated 3 times). Under a counter flow of
[8] a) Z. Li, S. X. Xiao, G. Q. Tian, A. G. Zhu, X. Feng, J. Liu,
Phosphorus Sulfur Silicon 2008, 183, 1124; b) Q. L. Shen, T.
Ogata, J. F. Hartwig, J. Am. Chem. Soc. 2008, 130, 6586; c) J. J.
Yin, M. M. Zhao, M. A. Huffman, J. M. McNamara, Org.
Lett. 2002, 4, 3481.
5900
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 5897–5901